Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy

Tendinopathy Clinical Trial

Official title:

Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02498795
• Other study ID #: P115/0017
• Status: Completed
• Phase: N/A
• Start date: January 1, 2019
• Est. completion date: May 2, 2020

Study information

• Verified date: December 2020
• Source: Universidad de Zaragoza
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The accomplishment of a treatment with Intratissue Percutaneous Electrolysis of additional form to the accomplishment of eccentric exercise's program in patients with chronic patellar tendinopathy is more effective than the accomplishment of an additional treatment with dry needling or eccentric exercise's program realized of isolated form.

Description:

Experimental study randomized with double blind, whose purpose is to compare three protocols in those who apply different protocols of physical therapy to themselves in three groups of intervention with patients with chronic patellar tendinopathy.

There take part in this study young women of both sexes, of Zaragoza and of different sports clubs of entity 18 and 40 years, that they realize of habitual form (minimum 3 times a week) a sport. All of them present chronic patellar tendinopathy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: May 2, 2020
• Est. primary completion date: December 31, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Age understood between 18 and 40 years.

• To practise any sport of habitual form.

• Patients diagnosed of chronic patellar tendinopathy with a minimum of 3 months of evolution and with stable symptomatology.

• Pain to the palpation of the tendon in the low pole of the knee and during the training or competition.

• Punctuation of the questionnaire VISA-P under 80.

Exclusion Criteria:

• Patient had an operation on the knee affected in the last 6 months.

• Infiltrations in the knee affected in the last 3 months.

• Patient who has received pharmacological treatment or physical therapy in the last 48 hours.

• Pathology with less than 3 months of evolution.

• To present bilateral chronic tendinopathy.

• Punctuation of the questionnaire major or equal Visa - p of 80.

• Inability to apply someone of the techniques of treatment or valuation for absolute or relative contraindication.

Related Conditions & MeSH terms

• Tendinopathy

Intervention

Other:
• Group of Dry Needling
Every group will receive a total of 4 treatment distributed throughout 8 weeks of treatment. The program of eccentric exercises that will have to realize it in his domicile every day.
• Group of Electrolysis
Every group will receive a total of 4 treatment distributed throughout 8 weeks of treatment. The program of eccentric exercises that will have to realize it in his domicile every day.
• Control Group
Every group will receive a total of 4 treatment distributed throughout 8 weeks of treatment. The program of eccentric exercises that will have to realize it in his domicile every day.

Locations

Country	Name	City	State
Spain	Universidad San Jorge	Villanueva de Gállego	Zaragoza

Sponsors (2)

Lead Sponsor	Collaborator
Universidad de Zaragoza	Universidad San Jorge

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline in functionality at 8 weeks as measured by Visa-p	This scale consists of eight questions, the first six questions of which employ an analogical visual scale in order to assign a score of 0 to 10, where 10 represents the optimum state, for the purpose of quantifying pain and function in different activities, whereas the last two questions assess the level of functionality and ability to perform physical activity.	8 weeks
Secondary	Pain, as measured by Visual Analog Scale	Participants will be explained that a score of 0 indicates the absence of pain whereas a score of 10 represents the maximum tolerable pain	0, 8 and 20 weeks
Secondary	Quality of life by SF-36	Health Survey	0, 8 and 20 weeks
Secondary	Thickness of the tendon, as measured by ultrasound scan	Tendon structure	0, 8 and 20 weeks
Secondary	Height of the jump	Jump test with a force platform	0, 8 and 20 weeks
Secondary	Concentric force of the low members	Jump test with a force platform	0, 8 and 20 weeks
Secondary	Speed of the jump	Jump test with a force platform	0, 8 and 20 weeks
Secondary	Hypervascularity, as measured by ultrasound scan	Tendon structure	0, 8 and 20 weeks
Secondary	Functionality, as measured by Visa-p	This scale consists of eight questions, the first six questions of which employ an analogical visual scale in order to assign a score of 0 to 10, where 10 represents the optimum state, for the purpose of quantifying pain and function in different activities, whereas the last two questions assess the level of functionality and ability to perform physical activity.	0 and 20 weeks